 SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 GLOBE NEWSWIRE -- CareDx, Inc. NASDAQ: CDNA, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the fourth quarter and full year ended December 31, 2020. 